TY - JOUR
T1 - Internal liquid crystal structures in nanocarriers containing drug hydrophobic ion pairs dictate drug release
AU - Ristroph, Kurt
AU - Salim, Malinda
AU - Wilson, Brian K.
AU - Clulow, Andrew J.
AU - Boyd, Ben J.
AU - Prud'homme, Robert K.
N1 - Funding Information:
This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. #DGE-1656466 awarded to K.D.R. the Bill and Melinda Gates Foundation (BMGF, OPP1150755), and the Innovation Fund from Princeton University. It was further supported by a Graduate Research Opportunities Worldwide (GROW) award for K.D.R. The SAXS experiments for this work were conducted on the SAXS/WAXS beamline of the Australian Synchrotron, part of ANSTO. This work was partly supported by the Australian Government through a Discovery Early Career Research Award awarded to A.J.C. (DE190100531).
Funding Information:
This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. # DGE-1656466 awarded to K.D.R., the Bill and Melinda Gates Foundation (BMGF, OPP1150755), and the Innovation Fund from Princeton University. It was further supported by a Graduate Research Opportunities Worldwide (GROW) award for K.D.R. The SAXS experiments for this work were conducted on the SAXS/WAXS beamline of the Australian Synchrotron, part of ANSTO. This work was partly supported by the Australian Government through a Discovery Early Career Research Award awarded to A.J.C. ( DE190100531 ).
Publisher Copyright:
© 2020
PY - 2021/1/15
Y1 - 2021/1/15
N2 - Hypothesis: Hydrophobic ion pairing (HIP), a solubility engineering technique in which ionic hydrophilic molecules are paired with a hydrophobic counterion, is an attractive strategy for encapsulating ionic water-soluble species into nanocarriers (NCs). Drug release from NCs containing HIP complexes is sensitive to ionic strength, pH, and drug:counterion charge ratio, but the exact mechanism for this was unknown, as was the underlying microstructure inside the NCs. We hypothesize that HIP complexes arrange into liquid crystalline structures in NC cores and that these structures are responsible for salt- and pH-dependent release. Experiment: A model hydrophobic ion pair from the cationic antimicrobial peptide polymyxin B sulfate and the anionic counterion sodium oleate is encapsulated into ~100 nm NCs formed using Flash NanoPrecipitation (FNP) and stabilized with an amphiphilic diblock copolymer, poly(caprolactone)-b-poly(ethylene glycol). Internal structures are observed using synchrotron small angle X-ray scattering (SAXS) and transmission electron microscopy (TEM) following NC formulation and are found to vary with polymyxin:oleate charge ratio. In vitro drug release is also measured with changes in pH and two charge ratio. Findings: For a formulation containing a four-fold charge excess of oleate relative to polymyxin, internal structures rearranged from a lamellar phase into an inverse hexagonal phase. The hexagonal phase formation corresponds to a greatly reduced rate of polymyxin release, suggesting that the polymyxin was incorporated into the center of hexagonally-packed rods. When release tests were repeated using phosphate-buffered saline (PBS) at pH 2.0 to ensure protonation of the oleic acid, all internal structures were eliminated and release occurs much faster than at neutral pH, regardless of charge ratio. These findings shed light on the mechanism behind stimulus-responsive drug release from systems containing hydrophobic ion pairs and enable the rational design of controlled-release formulations by manipulating the formation and dynamics of liquid crystalline phases inside NCs.
AB - Hypothesis: Hydrophobic ion pairing (HIP), a solubility engineering technique in which ionic hydrophilic molecules are paired with a hydrophobic counterion, is an attractive strategy for encapsulating ionic water-soluble species into nanocarriers (NCs). Drug release from NCs containing HIP complexes is sensitive to ionic strength, pH, and drug:counterion charge ratio, but the exact mechanism for this was unknown, as was the underlying microstructure inside the NCs. We hypothesize that HIP complexes arrange into liquid crystalline structures in NC cores and that these structures are responsible for salt- and pH-dependent release. Experiment: A model hydrophobic ion pair from the cationic antimicrobial peptide polymyxin B sulfate and the anionic counterion sodium oleate is encapsulated into ~100 nm NCs formed using Flash NanoPrecipitation (FNP) and stabilized with an amphiphilic diblock copolymer, poly(caprolactone)-b-poly(ethylene glycol). Internal structures are observed using synchrotron small angle X-ray scattering (SAXS) and transmission electron microscopy (TEM) following NC formulation and are found to vary with polymyxin:oleate charge ratio. In vitro drug release is also measured with changes in pH and two charge ratio. Findings: For a formulation containing a four-fold charge excess of oleate relative to polymyxin, internal structures rearranged from a lamellar phase into an inverse hexagonal phase. The hexagonal phase formation corresponds to a greatly reduced rate of polymyxin release, suggesting that the polymyxin was incorporated into the center of hexagonally-packed rods. When release tests were repeated using phosphate-buffered saline (PBS) at pH 2.0 to ensure protonation of the oleic acid, all internal structures were eliminated and release occurs much faster than at neutral pH, regardless of charge ratio. These findings shed light on the mechanism behind stimulus-responsive drug release from systems containing hydrophobic ion pairs and enable the rational design of controlled-release formulations by manipulating the formation and dynamics of liquid crystalline phases inside NCs.
KW - Controlled release
KW - Drug delivery
KW - Flash NanoPrecipitation
KW - Hydrophobic ion pairing
KW - Nanocarrier
KW - Small-angle X-ray scattering
UR - http://www.scopus.com/inward/record.url?scp=85090364415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090364415&partnerID=8YFLogxK
U2 - 10.1016/j.jcis.2020.08.045
DO - 10.1016/j.jcis.2020.08.045
M3 - Article
C2 - 32911422
AN - SCOPUS:85090364415
SN - 0021-9797
VL - 582
SP - 815
EP - 824
JO - Journal of Colloid And Interface Science
JF - Journal of Colloid And Interface Science
ER -